Immediate Impact
5 standout
Citing Papers
Persistent SARS-CoV-2 infection: significance and implications
2024 Standout
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients
2023 Standout
Works of Marcos López‐Dosil being referenced
Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Marcos López‐Dosil | 36 | 2 | 1 | 12 | 11 | 7 | 58 | |
| Tanaya Siripoon | 47 | 5 | 10 | 22 | 8 | 9 | 89 | |
| Eslam Saber Esmail | 57 | 11 | 13 | 10 | 9 | 79 | ||
| Mohamed Samir Abd El Ghafar | 55 | 4 | 13 | 6 | 5 | 67 | ||
| Raquel Ortiz | 14 | 2 | 19 | 22 | 9 | 84 | ||
| Rebeca Santano | 95 | 7 | 8 | 11 | 8 | 172 | ||
| Audrey Fraser | 29 | 71 | 6 | 38 | 6 | 192 | ||
| Victor Antonio Monroy Colín | 30 | 12 | 1 | 6 | 15 | 8 | 60 | |
| Mihaela Zaharia | 54 | 1 | 8 | 23 | 7 | 83 | ||
| Ruchee Shrestha | 48 | 11 | 2 | 20 | 6 | 9 | 92 | |
| Batsheva Marcos | 29 | 7 | 1 | 5 | 23 | 6 | 184 |
All Works
Login with ORCID to disown or claim papers
Loading papers...